We use cookies and analytics to understand how the site is used and to keep the service free. Choose Accept All to allow this, or Essential Only to use just the cookies we need to keep the site working. You can change your choice any time in our Cookie Policy

UK Edition

AdvertiseSubmit Company

Pharma JournalEvidence-Based Pharmaceutical Intelligence

Home Directory Blog Clinical Trials Industry News About Advertise Contact

Home›Blog

INSIGHTS & ANALYSIS

Industry Intelligence

Evidence-based coverage of pharmaceutical development, regulatory affairs, and biotech innovation

Clinical Trials29 June 2026· 11 min read

UK sets pathway for in vivo CRISPR gene editing trials

The UK is advancing in vivo CRISPR gene editing beyond ex vivo models. Explore regulatory signals, lipid nanoparticle delivery, and NHS reimbursement challenges.

By Dr. Eleanor Vance, Regulatory Affairs Editor

Cancer4 March 2026· 8 min read

NHS expands abiraterone access for high-risk prostate

NHS England has widened abiraterone acetate access for adults with high-risk non-metastatic prostate cancer, with treatment expected to reach eligible patients within weeks. The change matters because

By Tom Okafor, Clinical Trials Correspondent

Pharmacy29 October 2025· 15 min read

Oramorph dose and clinical guidance for 2025 supports safe prescribing

Oral morphine sulphate supplied as Oramorph remains a first-line strong opioid when moderate to severe pain does not respond to weaker agents. The immediate release formulation supports fast onset, sh

By James Whitfield, Manufacturing & Supply Chain Writer

Explore Topics

Pharmaceutical Companies›Biotechnology›Clinical Research›Contract Manufacturing›Medical Devices, Diagnostics & Equipment›Consulting, Advisory & MedComms›Lab, Reagents & Research Tools›Recruitment & Talent›Industry Media & Associations›Oncology›Rare Diseases›Immunology & Inflammation›

Recent Articles

NHS expands abiraterone access for high-risk prostate

Oramorph dose and clinical guidance for 2025 supports safe prescribing

29 October 2025

Stay Informed

Pharmaceutical intelligence, trials and regulatory news, straight to your inbox.

Stay ahead of the curve

Subscribe to our weekly pharmaceutical intelligence digest

Your trusted source for pharmaceutical industry intelligence. Covering drug development, regulatory affairs, clinical trials, and biotech innovation across the UK and global markets.

Weekly Briefing

Stay Ahead of the Industry

Join 2,500+ pharma professionals receiving weekly analysis, regulatory updates, and market intelligence.

Subscribe Free →

Editorial

Latest Articles
Research
Pharmaceutical
Clinical Trials
News
Technology

Directory

Company Directory
Submit Your Company
Advertise With Us
Media Kit
Search

About

About Pharma Journal
Editorial Standards
Contact Us
Newsletter

Contact

editorial@pharma-journal.com

advertising@pharma-journal.com

London, United Kingdom
Serving the global pharma industry

🔒SSL Secured

📋GDPR Compliant

✓Editorial Independence

🏛️ABPI Guidelines

Terms & Conditions Privacy Policy Cookie Policy Accessibility

© 2026 Pharma JournalPowered by TEKSYTE LTD

Browse

Popular Categories in Pharma Journal

Oncology Biotechnology Pharmaceutical Companies Clinical Research Regulatory, Quality & Compliance Medical Devices, Diagnostics & Equipment Immunology & Inflammation

Neuroscience & CNS Infectious Disease & Vaccines Rare Diseases Animal & Veterinary Health Industry Media & Associations Cell & Gene Therapy Dermatology & Aesthetics

Genomics & Precision Medicine Respiratory Cardiovascular & Metabolic Contract Manufacturing Consulting, Advisory & MedComms Haematology Ophthalmology

Private Medical Clinics (London)Recruitment & Talent Digital Health & AI Fertility & IVF Lab, Reagents & Research Tools Medical & Health Insurance Women's Health